Pages

Saturday, August 12, 2023

Ivermectin --- Zero Hedge -- August 12, 2023

Locator: 45434COVID.

I've lost all interest in this subject. The truth is out there.

But to close the loop. And why it is important from an investor's point of view.

A lot of folks are mis-reading this story. 

The U of M conducted the definitive study.  

The blog caught the story back on October 10, 2021. Today, the blog will post the link to the results of that study.

Links:

The FDA does not prohibit physicians from prescribing "off-label." State licensing boards and other health organizations have responsibility for monitoring / "regulating" physicians. The FDA comments carry great weight but the FDA does not prohibit physicians from prescribing "off-label." The lower court agreed; now in appellate court.

For an investor, why this is important: Pfizer's unexpected strength -- bullish case emerges amid new Covid-19 wave

By the way, the blog noted the "new wave" in a blog posted yesterday; not sure if national media has reported on this new wave. Indications are the new wave began in Minnesota - North Dakota? If so, maybe that's why it hasn't caught the attention of ABC, NBC, or CBS yet.

From the blog, October 10, 2021:

*******************************
Covid-19 Therapy Randomized Trial

Finally.

A randomized trial sponsored by University of Minnesota, others. Link here.

The study is 14 days of taking the study drugs or placebo pills twice per day. All of these medications are FDA-approved for both adults and children.
You are randomly assigned to 1 of 6 possible treatment groups:

  • Metformin (*immediate release)
  • Ivermectin
  • Fluvoxamine
  • Fluvoxamine + Metformin*
  • Ivermectin + Metformin*
  • Placebo
*There is an FDA recall of metformin extended release, but not immediate release (the kind used in this study). The recall has to do with a substance in the water purification process, not the metformin itself. Ivermectin treatment is only for 3 days, not 14 days.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.